Zoetis Inc. (ZTS) Financials

ZTS Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2026 15.1 billion 11.8 billion
June 30, 2026 15.1 billion 11.9 billion
March 31, 2026 15.2 billion 11.9 billion
Dec. 31, 2025 15.5 billion 12.1 billion

ZTS Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 717.0 million 27.0 million
June 30, 2026 538.0 million 26.0 million
March 31, 2026 291.0 million 25.0 million
Dec. 31, 2025 732.0 million 22.0 million

ZTS Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2026 591.0 million
June 30, 2026 691.0 million
March 31, 2026 601.0 million
Dec. 31, 2025 603.0 million

ZTS Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 1.5 billion 8.3 billion 188.0 million
June 30, 2026 1.7 billion 9.0 billion 190.0 million
March 31, 2026 1.9 billion 9.0 billion 193.0 million
Dec. 31, 2025 2.3 billion 9.2 billion 202.0 million

ZTS Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 411.6 million
June 30, 2026 417.7 million
March 31, 2026 422.4 million
Dec. 31, 2025 438.6 million

ZTS Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 107.0 million 174.0 million 582.0 million -
June 30, 2026 117.0 million 173.0 million 592.0 million -
March 31, 2026 110.0 million 180.0 million 588.0 million -
Dec. 31, 2025 161.0 million 199.0 million 619.0 million -

ZTS Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 2.4 billion 698.0 million
June 30, 2026 2.5 billion 673.0 million
March 31, 2026 2.3 billion 641.0 million
Dec. 31, 2025 2.4 billion 743.0 million

ZTS Revenue by Segment

Graph available only for paid members. Upgrade to see it.

ZTS

List: Contenders

Price: $79.73

52 week price:
68.31
148.79

Dividend Yield: 2.53%

5-year range yield:
0.48%
2.84%

Forward Dividend Yield: 2.66%

Payout Ratio: 33.88%

Payout Ratio Range:
-116.22%
4077.78%

Dividend Per Share: 2.12 USD

Earnings Per Share: 5.88 USD

P/E Ratio: 14.04

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 1.6 million

Ebitda: 543.0 million

Market Capitalization: 33.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 14

DGR3: 15.44%

DGR5: 20.27%

DGR10: 20.94%

Links: